Pilar Díz

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study

Pilar Díz, Alfonso Otero-González, María Xosé Rodríguez‐Álvarez et al. · BMC Endocrine Disorders · 2013 · 544 citations · Full text

Medicine, Endocrinology, Diabetology +13

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

Rafael Rosell, Kathleen D. Danenberg, V. Alberola et al. · Clinical Cancer Research · 2004 · 358 citations · Full text

Life Sciences, Molecular Biology, Oncology +11

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

H. Cortés-Funes, Carlos Gegúndez Gómez, Rafael Rosell et al. · Annals of Oncology · 2005 · 231 citations · Full text

Medicine, Oncology, Pharmacology +11

Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial

V. Alberola, Carlos Camps, Mariano Provencio et al. · Journal of Clinical Oncology · 2003 · 193 citations

Medicine, Oncology, Pharmacology +14

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

Rafael Rosell, Laia Perez‐Roca, José Javier Sánchez et al. · PLoS ONE · 2009 · 160 citations · Full text

Medicine, Oncology, Pharmacology +14